These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 10268396)

  • 1. A lab-pharmacy push to cut drug therapy costs.
    Rydzewski MM
    MLO Med Lab Obs; 1984 Oct; 16(10):63-4, 69. PubMed ID: 10268396
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving budget control: a case study.
    Karali J
    Hosp Cost Manag Account; 1993 May; 5(2):1-8. PubMed ID: 10125473
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring antibiotic prescriptions can reduce use and cost of drugs.
    Douglas AS
    Mod Healthc; 1984 Oct; 14(13):106-7. PubMed ID: 10268397
    [No Abstract]   [Full Text] [Related]  

  • 6. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacy. Target drug programs can reduce some costs and avoid others.
    Cost Containment; 1984 Aug; 6(16):3-6. PubMed ID: 10267698
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost benefit of pharmacy audit and nonrestrictive antibiotic policy.
    Ware GJ; Ford DJ
    N Z Med J; 1993 Apr; 106(954):160. PubMed ID: 8479665
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlling moxalactam and cefotaxime use with a target drug program.
    Abramowitz PW; Ludwig DJ; Mansur JM; Nold EG
    Hosp Pharm; 1983 Aug; 18(8):416-20. PubMed ID: 10261791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cephalosporin cost reduction.
    Martucci HJ; Parry MF
    Hosp Formul; 1981 Apr; 16(4):396-8, 403. PubMed ID: 10250718
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of drug costs within diagnosis related groups.
    Kolar R; Stanaszek W; Osborne J; Dougherty K
    Hosp Pharm; 1984 Nov; 19(11):731-5. PubMed ID: 10310864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical interventions reduce antimicrobial costs.
    Rao S; Machuga D
    Am J Hosp Pharm; 1994 Mar; 51(5):703. PubMed ID: 8203395
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of parenteral cephalosporin regulation on pharmacy costs.
    Ryan JL; Francese J
    Hosp Formul; 1983 May; 18(5):510-2. PubMed ID: 10260198
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacist-physician cooperation in the use of high-cost drugs.
    Oddis JA
    Resid Staff Physician; 1988 May; 34(6):13, 16. PubMed ID: 10287353
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost savings realized from interchanging ceftizoxime for cefoxitin.
    Guastella C
    Am J Hosp Pharm; 1988 Nov; 45(11):2376-7. PubMed ID: 3228095
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic therapy intervention at a community hospital. Opportunities for cost and quality improvements.
    Thrasher CM; Stefl ME; Dorner FH
    Hosp Top; 1995; 73(2):12-5. PubMed ID: 10144621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP; Sketris IS; Merrett RA; Marrie TJ
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug cost containment in the hospital.
    Smith WE
    Hosp Formul; 1978 Sep; 13(9):695-8. PubMed ID: 10238490
    [No Abstract]   [Full Text] [Related]  

  • 20. A pharmacy-based antibiotic UR program.
    Cohen SS
    QRB Qual Rev Bull; 1984 Jan; 10(1):22-5. PubMed ID: 6422381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.